|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Loss from continuing operations | |||||
| Adjustments to reconcile net loss from continuing operations to net cash used in operating activities - continuing operations: | |||||
| Depreciation and amortization | |||||
| Deferred income taxes | |||||
| Noncash lease expense | |||||
| Stock-based compensation expense | |||||
| Litigation settlement reserve | |||||
| Provision for doubtful accounts | |||||
| Loss on seizure of cash | |||||
| Extinguishment of discontinued operations liabilities | |||||
| Reduction of merchant reserve | |||||
| Unrealized loss on investment | |||||
| Loss on disposal of property, plant and equipment | |||||
| Changes in operating assets and liabilities, net of effects of discontinued operations: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Other current liabilities | |||||
| Lease liability | |||||
| Deferred revenue | |||||
| Net cash used in operating activities - continuing operations | |||||
| Net cash used in operating activities - discontinued operations | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Costs incurred to develop technology | |||||
| Purchases of property and equipment | |||||
| Payments to acquire investments | |||||
| Acquisition of Expo Experts | |||||
| Expo Experts | |||||
| Total acquisition of Expo Experts | |||||
| Additional Investment in nonontrolling subsidiary | |||||
| Purchases of intangible assets | |||||
| Net cash used in investing activities - continuing operations | |||||
| Net cash provided by investing activities - discontinued operations | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from the sale of Common Stock | |||||
| Repurchases of common stock | |||||
| Proceeds from (Repayment of) short-term debt | |||||
| Proceeds from Noncontrolling Interests | |||||
| Net cash provided by financing activities - continuing operations | |||||
| Net cash provided by financing activities - discontinued operations | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate fluctuations on cash and cash equivalents | |||||
| Net (decrease) increase in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash, beginning of period | |||||
| Cash, cash equivalents, and restricted cash, end of period | |||||
| Supplemental disclosures of other cash flow information: | |||||
| Non-cash stock issuance | |||||
| Commitment Funding | |||||
| Acquisition Stock Issuance | |||||
| QBSG Limited Investment | |||||
| Remote More | |||||
| Copyrights | |||||
| Cash paid for income taxes | |||||
| Non-cash amortization of commitment funding | |||||
| Conversion from Note Payable to Common Stock | |||||
| Acquisition of DTT Tokens | |||||
Loading...